AVITA Medical (NAS:RCEL) Receivables Turnover

: 2.68 (As of Dec. 2022)

View and export this data going back to 2012. Start your Free Trial

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. AVITA Medical's Revenue for the three months ended in Dec. 2022 was $9.46 Mil. AVITA Medical's average Accounts Receivable for the three months ended in Dec. 2022 was $3.53 Mil. Hence, AVITA Medical's Receivables Turnover for the three months ended in Dec. 2022 was 2.68.

AVITA Medical Receivables Turnover Historical Data

The historical data trend for AVITA Medical's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AVITA Medical Annual Data

Trend

Jun13

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Dec22

Receivables Turnover

6.05

6.93

8.20

10.55

9.86

AVITA Medical Quarterly Data
	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22
Receivables Turnover																2.22	2.17	2.26	2.45	2.68

Competitive Comparison

For the Medical Devices subindustry, AVITA Medical's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Annual Data Quarterly Data

AVITA Medical Receivables Turnover Distribution

For the Medical Devices & Instruments industry and Healthcare sector, AVITA Medical's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where AVITA Medical's Receivables Turnover falls in comparison to its industry or sector. The grey bar indicates the Receivables Turnover's extreme value range as defined by GuruFocus.

AVITA Medical Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

AVITA Medical's Receivables Turnover for the fiscal year that ended in Dec. 2022 is calculated as

	Receivables Turnover (A: Dec. 2022 )
=	Revenue	/	Average Total Inventories
=	Revenue (A: Dec. 2022 )	/ (	(Accounts Receivable (A: Jun. 2021 )	+	Accounts Receivable (A: Dec. 2022 ))	/	count )
=	34.421	/ (	(3.467	+	3.515)	/	2 )
=	34.421	/	3.491
=	9.86

AVITA Medical's Receivables Turnover for the quarter that ended in Dec. 2022 is calculated as

	Receivables Turnover (Q: Dec. 2022 )
=	Revenue	/	Average Total Inventories
=	Revenue (Q: Dec. 2022 )	/ (	(Accounts Receivable (Q: Sep. 2022 )	+	Accounts Receivable (Q: Dec. 2022 ))	/	count )
=	9.455	/ (	(3.553	+	3.515)	/	2 )
=	9.455	/	3.534
=	2.68

AVITA Medical (NAS:RCEL) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.

AVITA Medical Receivables Turnover Related Terms

Thank you for viewing the detailed overview of AVITA Medical's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.

AVITA Medical (NAS:RCEL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » AVITA Medical Inc (NAS:RCEL) » Definitions » Receivables Turnover

Comparable Companies

Traded in Other Exchanges

AVHHL:USA 51KB:Germany AVH:Australia

Address

28159 Avenue Stanford, Suite 220, Valencia, Los Angeles, CA, USA, 91355

Website

https://www.avitamedical.com

Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult patients in the U.S. with paediatric clinical trials and expanded indications in soft-tissue reconstruction and vitiligo underway. It is currently in roll-out across the approximately 136 U.S. burn centres. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the U.S. region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the U.S.

Executives

James Corbett	director	2 GOODYEAR, IRVINE CA 92618
Jan Stern Reed	director	C/O JAN STERN REED BAXTER INTERNATIONAL, ONE BAXTER PARKWAY DF2 2W, DEERFIELD IL 60015
Michael Holder	officer: Chief Financial Officer	6170 RESEARCH RD., STE 103, FRISCO TX 75034
Kathy M. Mcgee	officer: Chief Operating Officer	C/O AVITA MEDICAL, 28159 AVENUE STANFORD, SUITE 220, VALENCIA CA 91355
Sean Ekins	officer: Sr. VP of Finance	C/O AVITA MEDICAL, 28159 AVENUE STANFORD, SUITE 220, VALENCIA CA 91355
Jeremy Curnock Cook	director	TARGETED GENETICS CORP, 1100 OLIVE WAY STE 100, SEATTLE WA 98101
Michael S Perry	director, officer: Chief Executive Officer	C/O BIOTRANSPLANT INC, 196 BOSTON AVE SUITE 2800, MEDFORD MA 02155
Damien Mcdonald	director	5 MERCHANT SQUARE, NORTH WHARF ROAD, LONDON X0 W21AY
Erin Liberto	officer: Chief Commercial Officer	C/O AVITA MEDICAL, 28159 AVENUE STANFORD, SUITE 220, VALENCIA CA 91355
Donna Shiroma	officer: General Counsel	C/O AVITA MEDICAL, 28159 AVENUE STANFORD, SUITE 220, VALENCIA CA 91355
Andrew Quick	officer: Chief Technology Officer	C/O AVITA MEDICAL, 28159 AVENUE STANFORD, SUITE 200, VALENCIA CA 91355
David Mcintyre	officer: Chief Financial Officer	SUITE 4 LEVEL 46 2 PARK STREET, SIDNEY C3 2000
Lou Panaccio	director	C/O AVITA MEDICAL, 28159 AVENUE STANFORD, SUITE 200, VALENCIA CA 91355
Timothy Rooney	officer: Chief Administrative Officer	C/O AVITA MEDICAL, 28159 AVENUE STANFORD, SUITE 220, VALENCIA CA 91355
Suzanne Crowe	director	C/O AVITA MEDICAL, 28159 AVENUE STANFORD, SUITE 220, VALENCIA CA 91355